$3.80
-0.11 (-2.81%)
Stereotaxis, Inc. (STXS)
CAPS Rating:
The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

RSS Headlines
Fool UK